Telomerase: An unusual target for cytotoxic agents

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Despite an impressive body of basic knowledge, the value of telomerase as a therapeutic target remains unknown. It is clear that development of anti-telomerase agents will offer unusual challenges, but with cancer remaining a major cause of morbidity and mortality, these challenges are worth confronting. Oligonucleotides represent an excellent option for animal studies aimed at better characterizing the efficacy and toxicity of anti-telomerase agents. Favorable results in these studies would pave the way for clinical trials that will offer the only definitive means for accessing the telomerase-cancer connection.

Original languageEnglish (US)
Pages (from-to)957-960
Number of pages4
JournalChemical Research in Toxicology
Issue number10
StatePublished - 2000

ASJC Scopus subject areas

  • Toxicology


Dive into the research topics of 'Telomerase: An unusual target for cytotoxic agents'. Together they form a unique fingerprint.

Cite this